|
Анестезиология и реаниматология №5 2009
Э. Ханзен Информация для
контакта: Почему нельзя переливать больному не обработанную аппаратом раневую кровь В работе приведена фактическая информация по различным клинически важным аспектам, связанным с реинфузией больным раневой и дренажной крови. Рассмотрены такие вопросы, как состав раневой и дренажной крови и его сравнение с составом донорской крови, а также раневой крови, но прошедшей обработку на селл-сейвере; эффективность (клиническая и экономическая) реинфузии больному не обработанной раневой и дренажной крови; осложнения, возникающие вследствие реинфузии больному необработанной раневой и дренажной крови, а также ряд других важных аспектов проблемы. Убедительно показано, что в настоящее время для клинического применения реинфузии необработанной на селл-сейвере раневой и дренажной крови нет ни клинических, ни юридических, ни экономических оснований. Реинфузироваться больному должна только кровь, прошедшая обработку на селл-сейвере. Ключевые слова: раневая и дренажная кровь, необработанная и обработанная на селл-сейвере, осложнения реинфузии необработанной раневой крови. ЛИТЕРАТУРА 2. Martin J., Robitaffle D., Perrault L. P. et al. Reinfusion of mediastinal blood after heart surgery. // Thorac Cardiovasc Surg. 2000; V. 120: P. 499—504. 3. Ayers D. C., Murray D. G., Duerr D. M. Blood salvage after total hip arthroplasty. // J. Bone Joint Surg. 1995; V. 77: P. 1347—1351. 4. Ouriel K., Shortell C. K., Green R. M., DeWeese J. A. Intraoperative autotransfusion in aortic surgery. // J. Vasc. Surg. 1993; V. 18: P. 16—22. 5. Ereth M. H., Oliver W. C., Santrach P. J. Intraoperative techniques to conserve autologous blood: red-cell salvage, platelet-rich plasma, and acute normovolemic hernodilution. // In: Spiess B. D., Counts R. B., Gould S. A., eds. Perioperative transfusion medicine. Baltimore: Williams & Wilkins; 1998: P. 325—350. 6. Khuri S. F. What do we know about blood that is retransfused without being processed? // In: Stehling L, ed. Perioperative autologous transfusion. Arlington CVA): American Association of Blood Banks; 1991: P. 103—109. 7. Keating E. M., Meding J. B. Perioperative blood management practices in elective orthopaedic surgery. // J. Am. Acad. Orthop. Surg. 2002; V. 10: P. 393—400. 8. Yomtovian R. Autologous transfusion complications. // In: Popovsky M. A., ed. Transfusion reactions. Bethesda: AABB; 1996: P. 237—280. 9. National heart, lung and blood institute expert panel on the use of autologous blood. Transfusion alert: use of autologous blood. // Transfusion. 1995; V. 35: P. 703—711. 10. Goodnough L. T. Risks of blood transfusion. // Crit Care Med. 2003; V. 31 (12 Suppl.): P. 678—686. 11. Clements D. H., Sculco T. P., Burke S. W., Mayer K., Levine D. B. Salvage and reinfusion of postoperative sanguineous wound drainage: a preliminary report. // J. Bone. Joint. Surg. 1992; V. 74: P. 646—651. 12. Evans R. L., Rubash H. E., Albrecht S. A. The efficacy of postoperative autotransfusion on total joint arthroplasty. // Orthop Nurs. 1993; V. 12: P. 2—8. 13. Goodnough L. T., Brecher M. E. Autologous blood transfusion. // Intern Med. 1998; V. 37: P. 238—245. 14. Faught C., Wells P., Fergusson D., Laupacis A. Adverse effects of methods for miniizmg allogeneic transfusion: a critical review of the literature. // Transfus Med. Rev. 1998; V. 12: P. 206—225. 15. Dzik W. H., Sherbume B. Intraoperative blood salvage: medical controversies. // Transfus Med Rev. 1990; V. 4: P. 208—235. 16. Yao Y. M., Redl H., Bahrami S., Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. // Inflamm. Res. 1998; V. 47: P. 201—210. 17. Laffey J. G., Boylan J. F., Cheng D. C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. // Anesthesiology. 2002; V. 97: P. 215—252. 18. Royal College of Physicians of Edinburgh. Consensus statement on red cell transfusion. // Transfus Med. 1994; V. 4: P. 177—178. 19. Standards for blood banks and transfusion services. 22nd ed. Bethesda: American Association of Blood Banks; 2003. 20. Standards for perioperative autologous blood collection and administration. Bethesda: American Association of Blood Banks; 2001. 21. Yawn D. H. Properties of salvaged blood. // In: Taswell H. F., Pineda A. A., eds. Autologous transfusion and hemotherapy. Boston: Blackwell Scientific; 1991: P. 194—206. 22. Turner M. L., Ironside J. W. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. // Blood Rev. 1998; V. 12: P. 255—268. 23. Williamson L. M. Leucocyte depletion of the blood supply— how will patients benefit? // Br. J. Haematol. 2000; V. 110: P. 256—272. 24. Guidance for perioperative autologous blood collection and administration. Bethesda: American Association of Blood Banks; 2002. 25. Autologous Transfusion Committee. Guidelines for blood recovery and reinfusion in surgery and trauma. Bethesda: American Association of Blood Banks; 1997. 26. Hansen E., Altmeppen J. Proposal for internal quality management in intra- and postoperative blood salvage. // Infus Ther Transfus Med. 2002; Bd. 29: S. 147—150. 27. Handel M., Winkler J., Hornlein R. F. et al. Influence of acid-citrate-dextrose anticoagulant on blood quality in retransfusion systems after total knee arthroplasty. // Arch. Orthop. Trauma. Surg. 2002; V. 122: P. 269—273. 28. Amestad J. P., Bengtsson A., Bengtson J. P. et al. Release of cytokines, polymorphonuclear elastase and terminal C5b-9 complement complex by infusion of wound drainage blood. // Acta. Orthop. Scand. 1995; V. 66: P. 334—338. 29. Bengtson J. P., Backman L., Stenqvist O. et al. Complement activation and reinfusion of wound drainage blood. // Anesthesiology. 1990; V. 73: P. 376—380. 30. Cross M. H. Cell salvage and leucodepletion. // Perfusion 2001; V. 16 (Suppl.): P. 61—66. 31. Dalen T., Bengtsson A., Brorsson B., Engstrom K. G. Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction. // Vox Sang. 2003; V. 85: P. 31—39. 32. Avail A., Hyllner M., Bengtsson J. P. et al. Greater increase in cytokine concentration after salvage with filtered blood than with washed red cells, but no difference in postoperative haemoglobin recovery. // Transfusion. 1999; V. 39: P. 271—276. 33. Teitel J. M., Robillard P., Rock G. A. et al. A review of research related to blood transfusion in Canada, 2000—2002. // Transfus. Med. 2004: V. 14: P. 195—203. 34. Klein H. G. Will blood transfusion ever be safe enough? // Transfus Med. 2001; V. 11: P. 122—124. 35. Allain J. P., Thomas I., Sauleda S. Nucleic acid testing for emerging viral infections. // Transfus. Med. 2002; V. 12: P. 275—283. 36. Krohn C. D., Reikeras O., Bjomsen S., Brosstad F. Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery. // Eur. J. Surg. 2001; V. 167: P. 168—172. 37. Duchow J., Ames M., Hess T., Seyfert U. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study. // J. Arthroplasty. 2001; V. 16: P. 844—849. 38. De Haan J., Schonberger J., Haan J. et al. Tissue-type plasminogen and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. // J. Thorac. Cardiovasc. Surg. 1993; V. 106: P. 1017—1023. 39. De Haan J., Boonstra P. W., Monnink S. H. et al. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. // Ann. Thorac. Surg. 1995; V. 59: P. 901—907. 40. Wixson R. L., Kwaan H. C., Spies S. M., Zimmer A. M. Reinfusion of postoperative drainage in total joint arthroplasty. // J. Arthroplasty. 1994; V. 9: P. 351—358. 41. Blevins F. T., Shaw B., Valeri C. R., Kasser J., Hall J. Reinfusion of shed blood after orthopaedic procedures in children and adolescents. // J. Bone Joint. Surg. 1993; V. 75: P. 363—371. 42. Kristiansson M., Soop M., Saraste L. et al. Cytokine and coagulation characteristics of retrieved blood after arthroplasty. // Intensive Care Med. 1995; V. 21: P. 989—995. 43. Axford T. C., Dearani J. A., Ragno G. et al. Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. // Arm. Thorac. Surg. 1994; V. 57: P. 615—622. 44. Blaylock R. C., Carlson K. S., Morgan J. M. et al. In vitro analysis of shed blood from patients undergoing total knee replacement surgery. // Am. J. Clin. Pathol. 1994; V. 101: P. 365— 369. 45. SchuIze H. J., Wendel H. D., Khalighi K. et al. The quality of autotransfused chest-drainage blood after cardiac surgery: a study of coagulation. // Thorac. Cardiovasc. Surg. 1996; V. 44: P. 183—187. 46. Flom-Halvorsen H. I., Ovrurn E., Tangen G. et al. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance. // J. Thorac. Cardiovasc. Surg. 1999; V. 118: P. 610—617. 47. Long G. W., Glover J. L., Bendick P. J. et al. Cell washing versus immediate reinfusion of intraoperatively shed blood during abdominal aortic aneurysm repair. // Am. J. Surg. 1993; V. 166: P. 97—102. 48. Roberts D. R., Mah E. T., Nyman T. L., Davis R. W. Quality of blood prepared for autotransfusion in primary cemented total hip replacement. // Anaesth. Intensive Care. 1991: V. 19: P. 382—387. 49. Arnestad J. P., Bengtsson A., Bengtson J. P. et al. Formation of cytokines by retransfusion of shed whole blood. // Br. J. Anaesth. 1994; V. 72: P. 422—425. 50. Krohn C. D., Reikeras O., Mollnes T. E. Complement activation and increased systemic and pulmonary vascular resistance indices during infusion of postoperatively drained untreated blood. // Br. J. Anaesth. 1999; V. 82: P. 47—51. 51. Krohn C. D., Reikeras O., Aasen A. O. The cytokines IL-lbeta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL-10 in drained systemic blood after major orthopaedic surgery. // Eur. J. Surg. 1999; V. 165: P. 101—109. 52. Andersson I., Tylman M., Bengtsson J. P., Bengtsson A. Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee surgery. // Can. J. Anesth. 2001; V. 48: P. 251—255. 53. Dalen T., Brostrom L. A., Engstrom K. G. Cell quality of salvaged blood after total knee arthroplasty. // Acta Orthop. Scand. 1995; V. 66: P. 329—333. 54. Bengtsson A., Avail A., Hyllner M., Bengtson J. P. Formation of complement split products and proinflammatory cytokines by reinfusion of shed autologous blood. // Toxicol. Lett. 1998; V. 100: P. 129—133. 55. Amand T., Pincemail J., Blaffart F. et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardio-pulmonary bypass circuit. // Perfusion. 2002; V. 17: P. 117—123. 56. Southern E. P., Huo M. H., Mehta J. R., Keggi K. J. Unwashed wound drainage blood: what are we giving our patients? // Clin. Orthop. 1995; V. 320: P. 235—246. 57. Handel M., Winkler J., Hornlein R. F. et al. Increased interleukm-6 in collected drainage blood after knee arthroplasty. // Acta Orthop. Scand. 2001; V. 72: P. 270—272. 58. Schmidt H., Bendtzen K., Mortemen P. E. The inflammatory cytokine response after autotransfusion of shed mediastinal blood. // Acta Anaesthesiol. Scand. 1998; V. 42: P. 558—564. 59. Sieunarine K., Langton S., Lawrence-Brown M. M. D. Elastase levels in salvaged blood and the effect of cell washing. // Aust. NZ. J. Surg. 1990; V. 60: P. 613—616. 60. Mottl-link S., Russlies M., Klinger M. et al. Erythrocytes and proinflammatory mediators in wound drainage. // Vox Sang. 1998; V. 75: P. 205—211. 61. Hardaway R. M., Dumke R., Gee T. et al. The danger of hemolysis in shock. // Ann. Surg. 1979: V. 189: P. 373—376. 62. Davenport R. D. Hemolytic transfusion reactions. // In: Popovsky M. A. ed. Transfusion reactions. Bethesda: American Association of Blood Banks; 1996: P. 1—44. 63. Dalen T., Engstrom K. G. Microrheology of filtered autotransfusion drain blood with and without leukocyte reduction. // Clin. Hemorheol. Microcirc. 1999; V. 21: P. 113—123. 64. Engstrom K. G. The embolic potential of liquid fat in pericardial suction blood, and its elimination. // Perfusion. 2003; V. 18 (Suppl.): P. 69—74. 65. Murray D. J., Gress K., Weinstein S. L. Coagulopathy after re-infusion of autologous scavenged red blood cells. // Anesth. Analg. 1992; V. 75: P. 125—129. 66. Faris P. M., Ritter M. A., Keating E. M., Valeri C. R. Unwashed filtered shed blood collected after knee and hip arthroplasties: a source of autologous red blood cells. // J. Bone Joint Surg. 1991: V. 73: P. 1169—1178. 67. Wheeler T. J., Tobias J. D. Complications of autotransfusion with salvaged blood. // J. Post. Anesth. Nurs. 1994; V 9: P. 150—152. 68. Emergency Care Research Institute. Hemolysis and renal dysfunction associated with autotransfusion. // Health Devices. 1990; V. 19: P. 25—27. 69. Heath K. J., McFadzean W. A. Acute respiratory distress syndrome following autotransfusion with the Biosurge autotransfuser. // J. RArmy Med. Corps. 1995; V. 141: P. 105—106. 70. Woda R., Jetzlaff J. E. Upper airway oedema following autologous blood transfusion from wound drainage system. // Can. J. Anaesth. 1992. V. 39: P. 290—292. 71. Merrill B. S., Mitts D. L., Rogers W., Weinberg P. C. Autotransfusion: intraoperative use in ruptured ectopic pregnancy. // J. Reprod. Med. 1980; V. 24: P. 14—16. 72. Rubens F. D., Boodhwani M., Lavalee G., Mesana T. Perioperative red blood cell salvage. // Can. J. Anesth. 2003; V. 50 (6 Suppl.): P. S31—S40. 73. Zauder H. L., Stehling L. DIC after intraoperative autotransfusion. // Anesth Analg. 1993: V. 76: P. 1175—1176. 74. Milne A. A., Drummond G. B., Paterson D. A. et al. Disseminated intravascular coagulation after aneurysma repair, intraoperative salvage autotransfusion, and aprotinin. // Lancet. 1994: V. 344: P. 470—471. 75. Duncan S. E., Edwards W. H., Dale W. A. Caution regarding autotransfusion. // Surgery. 1974: V. 76: P. 1024—1030. 76. Vertrees R. A., Conti V. R., Lick S. D. et al. Adverse effects of postoperative infusion of shed mediastinal blood. // Ann. Thorac. Surg. 1996: V. 62: P. 717—723. 77. Mazer C. D. Con: Shed mediastinal blood should not be reinfused after cardiac surgery. // J. Cardiothorac. Vasc. Anesth. 1995; V. 9: P. 100—102. 78. Body S. C., Birmingham J., Parks R. et al. Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study. // J. Cardiothorac. Vasc. Anesth. 1999; V. 13: P. 10—16. 79. Dial S., Nguyen D., Menzies D. Autotransfusion of mediastinal blood: a risk factor for mediastimtis after cardiac surgery? Results of a cluster investigation. // Chest. 2003: V. 124: P. 1847—1851. 80. Kitano T., Hattori S., Miyakawa H. et al. Unwashed shed blood infusion causes deterioration in right ventricular function after coronary artery surgery. // Anaesth. Intensive Care. 2000; V. 28: P. 642—645. 81. Griffith L. D., Billman G. F., Daily P. O., Lane T. A. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. // Ann. Thorac. Surg. 1989; V. 47: P. 400—406. 82. Schmidt H., Mortensen P. E., Folsgaard S. L., Jensen E. A. Cardiac enzymes and autotransfusion of shed mediastinal blood after myocardial revascularization. // Ann. Thorac. Surg. 1997: V. 63: P. 1288—1292. 83. Wahl G. W., Feins R. H., Alfieres G., Bixby K. Reinfusion of shed blood after coronary operation causes elevation of cardiac enzyme levels. // Ann. Thorac. Surg. 1992: V. 53: P. 625—627. 84. Brooker R. F., Brown W. R., Moody D. M. et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. // Ann. Thorac. Surg. 1998; V. 65: P. 1651— 1655. 85. Azzopardi N., Yabri M. A fatal reaction following scavenged autologous blood transfusion. // Anaesth. Intensive Care. 1993: V. 21: P. 335—336. 86. Gould S. A., Forbes J. M. Controversies in transfusion medicine: Indications for autologous and allogeneic transfusion should be the same: Pro. // Transfusion. 1995; V. 35: P. 446— 449. 87. Huet C., Salmi L. R., Fergusson D. et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. // Anesth. Analg. 1999; V. 89: P. 861—869. 88. Dalrymple-Hay M. J. R., Dawkins S., Pack L. et al. Autotransfusion decreases blood usage following cardiac surgery — a prospective randomized trial. // Cardiovasc. Surg. 2001; V. 9: P. 184—187. 89. Rizzi L., Bertacchi P., Ghezzi L. M. et al. Postoperative blood salvage in hip and knee arthroplasty: a prospective study on cost effectiveness in 161 patients. // Acta Orthop. Scand. 1998; V. 69: P. 31—34. 90. Mauerhan D. R., Nussman D., Mokris J. G., Beaver W. B. Effect of postoperative reinfusion systems on hemoglobin levels in primary totalhip and total knee arthroplasties: a prospective randomized study. // J. Arthroplasty. 1993; V. 8: P. 523—527. 91. Adalberth G., Bystrom S., Kolstad K. et al. Postoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. // Acta Orthop. Scand. 1998; V. 69: P. 475— 478. 92. Niskanen R. O., Korkala O. L., Haapala J. et al. Drainage is of no use in primary uncomplicated cemented hip and knee arthroplasty for osteoarthritis: a prospective randomized study. // J. Arthroplasty. 2000; V. 15: P. 567—569. 93. Umlas J., Foster R. R., Dalai S. A. et al. Red cell loss following orthopedic surgery: the case against postoperative blood salvage. // Transfusion. 1994; V. 34: P. 402—406. 94. Schirmer U., Hemmer W., Lindner K. H. et al. Shed mediastinal blood in 500 elective cardiac surgery patients: is there enough for retransfusion routinely? // J. Cardiovasc. Surg. 1997; V. 38: P. 45—50. 95. Williamson K. R., Taswell H. F. Intraoperative blood salvage: a review. // Transfusion. 1991; V. 31: P. 662—665. 96. Gardner A., Gibbs N., Evans C., Bell R. Relative cost of autologous red cell salvage versus allogeneic red cell transfusion during abdominal aortic aneurysm repair. // Anaesth. Intensive Care. 2000; V. 28: P. 646—649. 97. Hansen E., Bechmann V., Altmeppen J. et al. Quality management in blood salvage: implementation of quality assurance and variables affecting product quality. // Transfus. Med. Hemother. 2004; V. 31: P. 221—227. |